Clinical trials
Phase 1 Retinal Vein Occlusion trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 6 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| California Retina Consultants | 2 |
| National Eye Institute (NEI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Targeted Therapy Technologies, LLC | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| David M. Brown, M.D. | 1 |
| Fovea Pharmaceuticals SA | 1 |
| Glenn Jaffe | 1 |
| Kodiak Sciences Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Vein Occlusion | 23 |
| Macular Edema | 8 |
| Macular Degeneration | 5 |
| Retinal Diseases | 4 |
| Diabetic Retinopathy | 3 |
| Choroidal Neovascularization | 2 |
| Epiretinal Membrane | 2 |
| Inflammation | 2 |
| Uveitis, Intermediate | 2 |
| Bites and Stings | 1 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.